EM1611F "Small Cell Lung Cancer – New Insights, Novel Therapeutics, Renewed Hope" (IM GR-111816)

The purpose of this presentation is to define current standards of care and future therapeutic research directions in the treatment of small cell lung cancer.

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Describe the current epidemiology of small cell lung cancer.
  • Know the current standard of care for small cell lung cancer by stage of disease
  • Be aware of the new molecular targets being currently explored for the treatment of small cell lung cancer
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
11/29/2016
Course expires: 
12/27/2016
Cost:
$0.00

Charles M. Rudin, M.D., Ph.D.
Chief, Thoracic Oncology Service
Co-Director, Druckenmiller Center for Lung Cancer Research
Sylvia Hassenfeld Chair in Lung Cancer Research
Memorial Sloan Kettering Cancer Center, New York City, New York
Pamela Hearn Isom Visiting Lectureship Honoring Eugene P. Frenkel, M.D.

Available Credit

  • 1.00 AMA

Accreditation Period

Course opens: 
11/29/2016
Course expires: 
12/27/2016

Price

Cost:
$0.00
Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome